SG11201401835VA - Ultra-concentrated rapid-acting insulin analogue formulations - Google Patents
Ultra-concentrated rapid-acting insulin analogue formulationsInfo
- Publication number
- SG11201401835VA SG11201401835VA SG11201401835VA SG11201401835VA SG11201401835VA SG 11201401835V A SG11201401835V A SG 11201401835VA SG 11201401835V A SG11201401835V A SG 11201401835VA SG 11201401835V A SG11201401835V A SG 11201401835VA SG 11201401835V A SG11201401835V A SG 11201401835VA
- Authority
- SG
- Singapore
- Prior art keywords
- ultra
- acting insulin
- insulin analogue
- analogue formulations
- concentrated
- Prior art date
Links
- 229940123452 Rapid-acting insulin Drugs 0.000 title 1
- 108010026951 Short-Acting Insulin Proteins 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical class N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 1
- 239000004026 insulin derivative Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Microbiology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161552246P | 2011-10-27 | 2011-10-27 | |
| PCT/US2012/062423 WO2013063572A1 (en) | 2011-10-27 | 2012-10-29 | Ultra-concentrated rapid-acting insulin analogue formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201401835VA true SG11201401835VA (en) | 2014-09-26 |
Family
ID=48168643
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201401835VA SG11201401835VA (en) | 2011-10-27 | 2012-10-29 | Ultra-concentrated rapid-acting insulin analogue formulations |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9908925B2 (enExample) |
| EP (1) | EP2771026A4 (enExample) |
| JP (1) | JP2014533241A (enExample) |
| KR (1) | KR20150021011A (enExample) |
| CN (1) | CN104010652A (enExample) |
| AU (1) | AU2012328407A1 (enExample) |
| BR (1) | BR112014010139A2 (enExample) |
| IN (1) | IN2014CN03888A (enExample) |
| SG (1) | SG11201401835VA (enExample) |
| WO (1) | WO2013063572A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2015005662A (es) * | 2012-11-05 | 2015-08-20 | Univ Case Western Reserve | Analogos de insulina de una sola cadena de larga accion. |
| WO2015106269A2 (en) | 2014-01-13 | 2015-07-16 | Thermalin Diabetes, Llc | Rapid action insulin formulations and pharmaceutical delivery systems |
| AR099569A1 (es) | 2014-02-28 | 2016-08-03 | Novo Nordisk As | Derivados de insulina y los usos médicos de estos |
| CA2964918A1 (en) * | 2014-10-20 | 2016-04-28 | Case Western Reserve University | Halogenated insulin analogues of enhanced biological potency |
| SG10201809457YA (en) * | 2014-11-21 | 2018-11-29 | Merck Sharp & Dohme | Insulin receptor partial agonists |
| WO2016105545A2 (en) * | 2014-12-24 | 2016-06-30 | Case Western Reserve University | Insulin analogues with enhanced stabilized and reduced mitogenicity |
| WO2017032795A1 (en) | 2015-08-25 | 2017-03-02 | Novo Nordisk A/S | Novel insulin derivatives and the medical uses hereof |
| CA2996455A1 (en) | 2015-08-25 | 2017-03-02 | Novo Nordisk A/S | Novel insulin derivatives and the medical uses hereof |
| EP3341402A1 (en) | 2015-08-25 | 2018-07-04 | Novo Nordisk A/S | Novel insulin derivatives and the medical uses hereof |
| WO2017070617A1 (en) * | 2015-10-21 | 2017-04-27 | Case Western Reserve University | Diol-modified insulin analogues containing a glucose-regulated conformational switch |
| SG11201803911PA (en) | 2015-12-23 | 2018-07-30 | Univ Case Western Reserve | Encapsulation of ultra-stable insulin analogues with polymer melts |
| SG11202106168VA (en) * | 2018-12-11 | 2021-07-29 | Sanofi Sa | Insulin analogs having reduced insulin receptor binding affinity |
| FI4073097T3 (fi) | 2019-12-11 | 2024-08-13 | Novo Nordisk As | Uusia insuliinianalogeja ja niiden käyttötapoja |
| WO2024194897A1 (en) * | 2023-03-22 | 2024-09-26 | Council Of Scientific And Industrial Research An Indian Registered Body Incorporated Under The Regn. Of Soc. Act (Act Xxi Of 1860) | A glycation resistant insulin polypeptide and a method of preparing the same thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4992418A (en) * | 1987-07-17 | 1991-02-12 | Mount Sinai School Of Medicine | Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin |
| ATE93238T1 (de) | 1988-07-20 | 1993-09-15 | Novo Nordisk As | Menschliche insulinanalage und zubereitungen daraus. |
| US5474978A (en) | 1994-06-16 | 1995-12-12 | Eli Lilly And Company | Insulin analog formulations |
| US20030104981A1 (en) * | 1995-11-03 | 2003-06-05 | Jelena Mandic | Human insulin analogues |
| DE10114178A1 (de) | 2001-03-23 | 2002-10-10 | Aventis Pharma Gmbh | Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität |
| US7317000B2 (en) | 2001-12-02 | 2008-01-08 | Novo Nordisk A/S | Glucose-dependent insulins |
| WO2003048195A2 (en) | 2001-12-02 | 2003-06-12 | Novo Nordisk A/S | Glucose dependant release of insulin from glucose sensing insulin derivatives |
| RU2005131429A (ru) * | 2003-03-11 | 2006-05-10 | Ново Нордиск А/С (DK) | Фармацевтические препараты, включающие кислотно-стабилизированный инсулин |
| SE0401942D0 (sv) | 2004-07-28 | 2004-07-28 | Lipopeptide Ab | New antimicrobial peptide complexes |
| US20100298213A1 (en) | 2004-08-20 | 2010-11-25 | Novo Nordisk A/S | Pharmaceutically Active Insulin Receptor-Modulating Molecules |
| ES2554773T3 (es) * | 2006-10-04 | 2015-12-23 | Case Western Reserve University | Insulina y análogos de la insulina resistentes a la fibrilación |
| US8946148B2 (en) | 2007-11-20 | 2015-02-03 | Ambrx, Inc. | Modified insulin polypeptides and their uses |
| KR20110061552A (ko) * | 2008-07-31 | 2011-06-09 | 케이스 웨스턴 리저브 유니버시티 | 할로겐 안정화된 인슐린 |
| KR20120129875A (ko) * | 2008-07-31 | 2012-11-28 | 케이스 웨스턴 리저브 유니버시티 | 염소화 아미노산을 갖는 인슐린 유사체 |
| WO2010080606A1 (en) * | 2008-12-19 | 2010-07-15 | Indiana University Research And Technology Corporation | Insulin analogs |
-
2012
- 2012-10-29 AU AU2012328407A patent/AU2012328407A1/en not_active Abandoned
- 2012-10-29 US US14/354,667 patent/US9908925B2/en not_active Expired - Fee Related
- 2012-10-29 WO PCT/US2012/062423 patent/WO2013063572A1/en not_active Ceased
- 2012-10-29 CN CN201280064561.7A patent/CN104010652A/zh active Pending
- 2012-10-29 JP JP2014539111A patent/JP2014533241A/ja active Pending
- 2012-10-29 EP EP12843655.7A patent/EP2771026A4/en not_active Withdrawn
- 2012-10-29 KR KR20147011706A patent/KR20150021011A/ko not_active Withdrawn
- 2012-10-29 BR BR112014010139A patent/BR112014010139A2/pt not_active IP Right Cessation
- 2012-10-29 SG SG11201401835VA patent/SG11201401835VA/en unknown
-
2014
- 2014-05-23 IN IN3888CHN2014 patent/IN2014CN03888A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2771026A4 (en) | 2015-08-05 |
| IN2014CN03888A (enExample) | 2015-10-16 |
| WO2013063572A1 (en) | 2013-05-02 |
| EP2771026A1 (en) | 2014-09-03 |
| KR20150021011A (ko) | 2015-02-27 |
| BR112014010139A2 (pt) | 2017-04-25 |
| US9908925B2 (en) | 2018-03-06 |
| NZ624493A (en) | 2016-02-26 |
| AU2012328407A1 (en) | 2014-05-22 |
| JP2014533241A (ja) | 2014-12-11 |
| US20140323398A1 (en) | 2014-10-30 |
| CN104010652A (zh) | 2014-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201401835VA (en) | Ultra-concentrated rapid-acting insulin analogue formulations | |
| IL232345A0 (en) | A stable preparation for pest control | |
| ZA201106755B (en) | Fast-acting insulin formulation | |
| ZA201306118B (en) | Lyophilized formulations | |
| IL232305A0 (en) | pharmaceutical preparations | |
| GB201102237D0 (en) | Particle formulation | |
| HUE042611T2 (hu) | Új (trimetoxifenilamino)pirimidinil készítmények | |
| ZA201305986B (en) | Improved insecticide formulations | |
| ZA201206447B (en) | Stable pharmaceuticals composition comprising bisphosphonate | |
| GB201110278D0 (en) | Formulations | |
| ZA201201024B (en) | Pesticidal formulation | |
| GB201111577D0 (en) | Pharmaceutical formulations | |
| GB201105360D0 (en) | Formulations | |
| GB201111578D0 (en) | Pharmeutical formulations | |
| GB201111013D0 (en) | Formulations | |
| GB201107627D0 (en) | Formulations | |
| GB201107626D0 (en) | Formulations | |
| GB201102795D0 (en) | Formulations | |
| GB201104049D0 (en) | Formulations | |
| GB201104048D0 (en) | Formulations | |
| GB201105410D0 (en) | Formulations | |
| GB201110986D0 (en) | Sweet formulation | |
| AU2011900781A0 (en) | Insulin analogues |